When immunotherapy bleeds: severe hemorrhagic gastritis secondary to pembrolizumab

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)413-414
Number of pages2
JournalJournal of Gastrointestinal and Liver Diseases
Volume34
Issue number3
DOIs
StatePublished - Sep 26 2025

Keywords

  • hematemesis
  • pembrolizumab
  • Immune-related adverse events
  • gastritis

PubMed: MeSH publication types

  • Letter

Cite this